Presentation by a Cell Metric CLD customer in US about their use of the system in clone screening for cell line development.
This presentation is made available courtesy of Momenta Pharmaceuticals and IBC Conferences
US Pharma presentation on clone screen strategy for monoclonality using Solentim Cell Metric CLD
1. Efficient Screening Strategies to
Address Monoclonality & Reduce
Timelines
Chaomei He, Associate Director , Momenta Pharmaceuticals, Inc. USA
IBC 4th Annual Cell Line Development & Engineering Asia